Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

Saved in:
Bibliographic Details
Title: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Authors: Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., Kupka, R. W., Suppes, T., McElroy, S., Keck, P. E., Denicoff, K. D., Grunze, H., Kitchen, C. M. R., Mintz, J., Walden, J (AUTHOR)
Source: British Journal of Psychiatry. Aug2006, Vol. 189, p124-131. 8p.
Subjects: Bipolar disorder, Hypomania, Antidepressants, Sertraline, Venlafaxine, Outpatient medical care, Mood stabilizers, Placebos, Clinical trials
Abstract: Background: Few studies have examined the relative risks of switching into hypomania or mania associated with second-generation antidepressant drugs in bipolar depression.Aims: To examine the relative acute effects of bupropion, sertraline and venlafaxine as adjuncts to mood stabilisers.Method: In a 10-week trial, participants receiving out-patient treatment for bipolar disorder (stratified for rapid cycling) were randomly treated with a flexible dose of one of the antidepressants, or their respective matching placebos, as adjuncts to mood stabilisers.Results: A total of 174 adults with bipolar disorder I, II or not otherwise specified, currently in the depressed phase, were included. All three antidepressants were associated with a similar range of acute response (49-53%) and remission (34-41%). There was a significantly increased risk of switches into hypomania or mania in participants treated with venlafaxine compared with bupropion or sertraline.Conclusions: More caution appears indicated in the use of venlafaxine rather than bupropion or sertraline in the adjunctive treatment of bipolar depression, especially if there is a prior history of rapid cycling. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Psychiatry is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 25178526
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Post%2C+R%2E+M%2E%22">Post, R. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Altshuler%2C+L%2E+L%2E%22">Altshuler, L. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Leverich%2C+G%2E+S%2E%22">Leverich, G. S.</searchLink><br /><searchLink fieldCode="AR" term="%22Frye%2C+M%2E+A%2E%22">Frye, M. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Nolen%2C+W%2E+A%2E%22">Nolen, W. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Kupka%2C+R%2E+W%2E%22">Kupka, R. W.</searchLink><br /><searchLink fieldCode="AR" term="%22Suppes%2C+T%2E%22">Suppes, T.</searchLink><br /><searchLink fieldCode="AR" term="%22McElroy%2C+S%2E%22">McElroy, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Keck%2C+P%2E+E%2E%22">Keck, P. E.</searchLink><br /><searchLink fieldCode="AR" term="%22Denicoff%2C+K%2E+D%2E%22">Denicoff, K. D.</searchLink><br /><searchLink fieldCode="AR" term="%22Grunze%2C+H%2E%22">Grunze, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Kitchen%2C+C%2E+M%2E+R%2E%22">Kitchen, C. M. R.</searchLink><br /><searchLink fieldCode="AR" term="%22Mintz%2C+J%2E%22">Mintz, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Walden%2C+J%22">Walden, J</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Psychiatry%22">British Journal of Psychiatry</searchLink>. Aug2006, Vol. 189, p124-131. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Bipolar+disorder%22">Bipolar disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Hypomania%22">Hypomania</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Sertraline%22">Sertraline</searchLink><br /><searchLink fieldCode="DE" term="%22Venlafaxine%22">Venlafaxine</searchLink><br /><searchLink fieldCode="DE" term="%22Outpatient+medical+care%22">Outpatient medical care</searchLink><br /><searchLink fieldCode="DE" term="%22Mood+stabilizers%22">Mood stabilizers</searchLink><br /><searchLink fieldCode="DE" term="%22Placebos%22">Placebos</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <bold>Background: </bold>Few studies have examined the relative risks of switching into hypomania or mania associated with second-generation antidepressant drugs in bipolar depression.<bold>Aims: </bold>To examine the relative acute effects of bupropion, sertraline and venlafaxine as adjuncts to mood stabilisers.<bold>Method: </bold>In a 10-week trial, participants receiving out-patient treatment for bipolar disorder (stratified for rapid cycling) were randomly treated with a flexible dose of one of the antidepressants, or their respective matching placebos, as adjuncts to mood stabilisers.<bold>Results: </bold>A total of 174 adults with bipolar disorder I, II or not otherwise specified, currently in the depressed phase, were included. All three antidepressants were associated with a similar range of acute response (49-53%) and remission (34-41%). There was a significantly increased risk of switches into hypomania or mania in participants treated with venlafaxine compared with bupropion or sertraline.<bold>Conclusions: </bold>More caution appears indicated in the use of venlafaxine rather than bupropion or sertraline in the adjunctive treatment of bipolar depression, especially if there is a prior history of rapid cycling. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of British Journal of Psychiatry is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=25178526
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1192/bjp.bp.105.013045
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 124
    Subjects:
      – SubjectFull: Bipolar disorder
        Type: general
      – SubjectFull: Hypomania
        Type: general
      – SubjectFull: Antidepressants
        Type: general
      – SubjectFull: Sertraline
        Type: general
      – SubjectFull: Venlafaxine
        Type: general
      – SubjectFull: Outpatient medical care
        Type: general
      – SubjectFull: Mood stabilizers
        Type: general
      – SubjectFull: Placebos
        Type: general
      – SubjectFull: Clinical trials
        Type: general
    Titles:
      – TitleFull: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Post, R. M.
      – PersonEntity:
          Name:
            NameFull: Altshuler, L. L.
      – PersonEntity:
          Name:
            NameFull: Leverich, G. S.
      – PersonEntity:
          Name:
            NameFull: Frye, M. A.
      – PersonEntity:
          Name:
            NameFull: Nolen, W. A.
      – PersonEntity:
          Name:
            NameFull: Kupka, R. W.
      – PersonEntity:
          Name:
            NameFull: Suppes, T.
      – PersonEntity:
          Name:
            NameFull: McElroy, S.
      – PersonEntity:
          Name:
            NameFull: Keck, P. E.
      – PersonEntity:
          Name:
            NameFull: Denicoff, K. D.
      – PersonEntity:
          Name:
            NameFull: Grunze, H.
      – PersonEntity:
          Name:
            NameFull: Kitchen, C. M. R.
      – PersonEntity:
          Name:
            NameFull: Mintz, J.
      – PersonEntity:
          Name:
            NameFull: Walden, J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 00071250
          Numbering:
            – Type: volume
              Value: 189
          Titles:
            – TitleFull: British Journal of Psychiatry
              Type: main
ResultId 1